NL194578B - Farmaceutisch preparaat met cyclosporine. - Google Patents

Farmaceutisch preparaat met cyclosporine.

Info

Publication number
NL194578B
NL194578B NL8901902A NL8901902A NL194578B NL 194578 B NL194578 B NL 194578B NL 8901902 A NL8901902 A NL 8901902A NL 8901902 A NL8901902 A NL 8901902A NL 194578 B NL194578 B NL 194578B
Authority
NL
Netherlands
Prior art keywords
cyclosporine
pharmaceutical preparation
pharmaceutical
preparation
Prior art date
Application number
NL8901902A
Other languages
English (en)
Other versions
NL8901902A (nl
NL194578C (nl
Original Assignee
Biogal Gyogyszergyar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogal Gyogyszergyar filed Critical Biogal Gyogyszergyar
Publication of NL8901902A publication Critical patent/NL8901902A/nl
Publication of NL194578B publication Critical patent/NL194578B/nl
Application granted granted Critical
Publication of NL194578C publication Critical patent/NL194578C/nl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
NL8901902A 1988-07-21 1989-07-21 Farmaceutisch preparaat met cyclosporine. NL194578C (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU883796A HU201567B (en) 1988-07-21 1988-07-21 Process for production of intravenous medical compositions containing cyclosphorin
HU379688 1988-07-21

Publications (3)

Publication Number Publication Date
NL8901902A NL8901902A (nl) 1990-02-16
NL194578B true NL194578B (nl) 2002-04-02
NL194578C NL194578C (nl) 2002-08-05

Family

ID=10965544

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8901902A NL194578C (nl) 1988-07-21 1989-07-21 Farmaceutisch preparaat met cyclosporine.

Country Status (26)

Country Link
US (1) US5047396A (nl)
JP (1) JPH07116051B2 (nl)
KR (1) KR0137674B1 (nl)
AR (1) AR243382A1 (nl)
AT (1) AT402258B (nl)
AU (1) AU614862B2 (nl)
BE (1) BE1004323A4 (nl)
CA (1) CA1332712C (nl)
CH (1) CH679120A5 (nl)
DD (1) DD283934A5 (nl)
DE (1) DE3924207A1 (nl)
DK (1) DK175540B1 (nl)
FI (1) FI92556C (nl)
FR (1) FR2635265B1 (nl)
GB (1) GB2221157B (nl)
GR (1) GR1002184B (nl)
HU (1) HU201567B (nl)
IL (1) IL91069A (nl)
IT (1) IT1231434B (nl)
LU (1) LU87560A1 (nl)
NL (1) NL194578C (nl)
NO (1) NO175287C (nl)
NZ (1) NZ230036A (nl)
PT (1) PT91246B (nl)
SE (1) SE509174C2 (nl)
ZA (1) ZA895588B (nl)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6007840A (en) * 1988-09-16 1999-12-28 Novartis Ag Pharmaceutical compositions comprising cyclosporins
KR0148748B1 (ko) * 1988-09-16 1998-08-17 장 크라메르, 한스 루돌프 하우스 사이클로스포린을 함유하는 약학조성물
GB2251186A (en) * 1990-12-04 1992-07-01 Randall Neal Gatz Polypeptide for use in treatment of autoimmune disease
US6262022B1 (en) 1992-06-25 2001-07-17 Novartis Ag Pharmaceutical compositions containing cyclosporin as the active agent
GB9113872D0 (en) * 1991-06-27 1991-08-14 Sandoz Ag Improvements in or relating to organic compounds
ATE147619T1 (de) 1992-05-13 1997-02-15 Sandoz Ag Opthalmische zusammensetzungen enthaltend ein cyclosporin
ES2168271T3 (es) 1992-09-25 2002-06-16 Novartis Ag Composiciones farmaceuticas que contienen ciclosporinas.
DE4412201A1 (de) * 1993-04-20 1994-11-10 Rentschler Arzneimittel Neue pharmazeutische Zubereitungen zur oralen Verabreichung enthaltend Cyclosporin
CH686761A5 (de) 1993-05-27 1996-06-28 Sandoz Ag Galenische Formulierungen.
US20020099067A1 (en) * 1993-07-08 2002-07-25 Ulrich Posanski Pharmaceutical compositions for sparingly soluble therapeutic agents
TW406020B (en) * 1993-09-29 2000-09-21 Bristol Myers Squibb Co Stabilized pharmaceutical composition and its method for preparation and stabilizing solvent
DE4340781C3 (de) * 1993-11-30 2000-01-27 Novartis Ag Cyclosporin enthaltende flüssige Zubereitungen und Verfahren zu ihrer Herstellung
KR0146671B1 (ko) * 1994-02-25 1998-08-17 김충환 사이클로스포린-함유 분말 조성물
CA2231404C (en) 1994-11-03 2009-02-17 Arzneimittelwerk Dresden Gmbh Novel cyclosporine preparation forms for oral administration of simple composition and high bio-availability, and process for producing them
US5904935A (en) * 1995-06-07 1999-05-18 Alza Corporation Peptide/protein suspending formulations
US5962019A (en) * 1995-08-25 1999-10-05 Sangstat Medical Corporation Oral cyclosporin formulations
US5766629A (en) 1995-08-25 1998-06-16 Sangstat Medical Corporation Oral cyclosporin formulations
WO1997007787A1 (en) * 1995-08-25 1997-03-06 Sangstat Medical Corporation Oral cyclosporin formulations
US5834017A (en) * 1995-08-25 1998-11-10 Sangstat Medical Corporation Oral cyclopsporin formulations
US5827822A (en) * 1996-03-25 1998-10-27 Sangstat Medical Corporation Cyclosporin a formulations as nanoparticles
US20050053594A1 (en) * 1995-11-16 2005-03-10 Dario Alessi RAC-PK as a therapeutic agent or in diagnostics, screening method for agents and process for activating RAC-PK
DE19544507B4 (de) * 1995-11-29 2007-11-15 Novartis Ag Cyclosporin enthaltende Präparate
US5858401A (en) 1996-01-22 1999-01-12 Sidmak Laboratories, Inc. Pharmaceutical composition for cyclosporines
DE29824679U1 (de) 1997-01-30 2002-03-28 Novartis Ag Pharmazeutische Zusammensetzungen
JP4718653B2 (ja) * 1997-03-12 2011-07-06 アボツト・ラボラトリーズ シクロスポリンの投与のための親水性二成分系
US6008191A (en) * 1997-09-08 1999-12-28 Panacea Biotec Limited Pharmaceutical compositions containing cyclosporin
US6187747B1 (en) 1997-09-08 2001-02-13 Panacea Biotech Limited Pharmaceutical composition comprising cyclosporin
US6346511B1 (en) 1997-09-08 2002-02-12 Panacea Biotec Limited Pharmaceutical composition comprising cyclosporin
AT408186B (de) * 1998-12-15 2001-09-25 Sanochemia Pharmazeutika Ag Wässerige zubereitung von beta-carotin
US7732404B2 (en) 1999-12-30 2010-06-08 Dexcel Ltd Pro-nanodispersion for the delivery of cyclosporin
DE10015814A1 (de) * 2000-03-30 2001-10-11 Max Planck Gesellschaft Arzneimittel zur Stimulierung der Leukopoese, zur Behandlung von Tumor- und Protozoenerkrankungen und Verfahren zu seiner Herstellung
FR2826517B1 (fr) * 2001-06-20 2004-03-12 Somfy Dispositif d'alimentation pour store motorise ou similaire
AR036852A1 (es) * 2001-10-19 2004-10-06 Isotechnika Inc Preconcentrado de una microemulsion de analogos de ciclosporina, su metodo de preparacion y metodos para producir inmunosupresion
US6979672B2 (en) 2002-12-20 2005-12-27 Polichem, S.A. Cyclosporin-based pharmaceutical compositions
US20050059583A1 (en) 2003-09-15 2005-03-17 Allergan, Inc. Methods of providing therapeutic effects using cyclosporin components
US7288520B2 (en) * 2005-07-13 2007-10-30 Allergan, Inc. Cyclosporin compositions
US20070015691A1 (en) 2005-07-13 2007-01-18 Allergan, Inc. Cyclosporin compositions
US7276476B2 (en) * 2005-07-13 2007-10-02 Allergan, Inc. Cyclosporin compositions
US7297679B2 (en) * 2005-07-13 2007-11-20 Allergan, Inc. Cyclosporin compositions
US7202209B2 (en) 2005-07-13 2007-04-10 Allergan, Inc. Cyclosporin compositions
US20070015693A1 (en) * 2005-07-13 2007-01-18 Allergan, Inc. Cyclosporin compositions
US7501393B2 (en) * 2005-07-27 2009-03-10 Allergan, Inc. Pharmaceutical compositions comprising cyclosporins
US7745400B2 (en) * 2005-10-14 2010-06-29 Gregg Feinerman Prevention and treatment of ocular side effects with a cyclosporin
US9839667B2 (en) 2005-10-14 2017-12-12 Allergan, Inc. Prevention and treatment of ocular side effects with a cyclosporin
GB2451811A (en) 2007-08-09 2009-02-18 Ems Sa Delivery composition for solubilising water-insoluble pharmaceutical active ingredients
JP4815418B2 (ja) * 2007-10-19 2011-11-16 カヤバ工業株式会社 空圧緩衝器
WO2010029374A1 (en) * 2008-09-12 2010-03-18 Critical Pharmaceuticals Limited Improvements in the absorption of therapeutic agents across mucosal membranes or the skin
FR2948568B1 (fr) * 2009-07-30 2012-08-24 Sanofi Aventis Formulation pharmaceutique
PT2683406T (pt) 2011-03-11 2019-07-08 Beth Israel Deaconess Medical Ct Inc Anticorpos anti-cd40 e utilização dos mesmos
CN116063481A (zh) 2015-09-04 2023-05-05 普里玛托普医疗股份有限公司 人源化抗-cd40抗体及其用途

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3658M (fr) * 1964-02-18 1965-11-02 Michel Marie Andre Guerbet Composition huileuse pour l'injection intravasculaire.
DE2819094A1 (de) * 1977-05-10 1978-11-23 Sandoz Ag Cyclosporin-derivate, ihre verwendung und herstellung
DE2907460A1 (de) * 1978-03-07 1979-09-13 Sandoz Ag Neue resorbierbare galenische kompositionen
CH641356A5 (en) * 1979-02-27 1984-02-29 Sandoz Ag Pharmaceutical compositions containing cyclosporin
AU534955B2 (en) * 1980-01-23 1984-02-23 Sandoz Ag Cyclosporin a to treat lymphoproliferative disorders
DE3339235A1 (de) * 1983-10-28 1985-05-09 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung von polyurethanen
DE3339236A1 (de) * 1983-10-28 1985-05-09 Bayer Ag Arzneimittelzubereitung
EP0336976A4 (de) * 1987-10-02 1990-06-27 Vsesojuznyj Kardiologitsches Arzneimittelzubereitung zur behandlung der multiplen sklerose und der seitlichen amyotrophen sklerose.
GB8729153D0 (en) * 1987-12-14 1988-01-27 Efamol Ltd Fatty acid compositions
US4943560A (en) * 1988-04-06 1990-07-24 Regents Of The University Of Minnesota Solvent system for chronic vascular infusion of hydrophobic drugs
DE3832362A1 (de) * 1988-09-23 1990-03-29 Sandoz Ag Neue cyclopeptolide, verfahren zu ihrer herstellung und ihre verwendung

Also Published As

Publication number Publication date
AR243382A1 (es) 1993-08-31
KR900001364A (ko) 1990-02-27
DE3924207A1 (de) 1990-01-25
BE1004323A4 (fr) 1992-11-03
CH679120A5 (nl) 1991-12-31
LU87560A1 (fr) 1991-02-18
HUT50851A (en) 1990-03-28
FR2635265A1 (fr) 1990-02-16
DK362189A (da) 1990-01-22
NO175287B (no) 1994-06-20
IT1231434B (it) 1991-12-04
AU3884589A (en) 1990-02-01
PT91246B (pt) 1995-05-04
GB8916679D0 (en) 1989-09-06
FI893520A0 (fi) 1989-07-21
DK175540B1 (da) 2004-11-29
ZA895588B (en) 1990-07-25
GR1002184B (en) 1996-03-12
GB2221157B (en) 1991-12-18
DD283934A5 (de) 1990-10-31
ATA176789A (de) 1996-08-15
DE3924207C2 (nl) 1992-07-09
CA1332712C (en) 1994-10-25
JPH03115227A (ja) 1991-05-16
SE509174C2 (sv) 1998-12-14
KR0137674B1 (ko) 1998-05-15
FI92556C (fi) 1994-12-12
AT402258B (de) 1997-03-25
NZ230036A (en) 1991-02-26
SE8902588D0 (sv) 1989-07-21
JPH07116051B2 (ja) 1995-12-13
FI893520A (fi) 1990-01-22
DK362189D0 (da) 1989-07-21
NO892995L (no) 1990-01-22
GR890100467A (el) 1990-06-27
FI92556B (fi) 1994-08-31
NL8901902A (nl) 1990-02-16
NO175287C (no) 1994-09-28
NL194578C (nl) 2002-08-05
PT91246A (pt) 1990-02-08
US5047396A (en) 1991-09-10
AU614862B2 (en) 1991-09-12
HU201567B (en) 1990-11-28
IL91069A (en) 1993-07-08
IT8921259A0 (it) 1989-07-21
FR2635265B1 (fr) 1995-03-17
NO892995D0 (no) 1989-07-21
GB2221157A (en) 1990-01-31
SE8902588L (sv) 1990-01-22

Similar Documents

Publication Publication Date Title
NL194578B (nl) Farmaceutisch preparaat met cyclosporine.
NL195028B (nl) Cyclosporinebevattend farmaceutisch preparaat.
ATE98480T1 (de) Arzneimittelformulierungen.
DE68901417D1 (de) Pharmazeutische zusammensetzung.
DK0539319T3 (da) Farmaceutisk cyclosporinpræparat
DE68913415D1 (de) Oral-Präparate.
DE68917544D1 (de) Durchsichtiges Präparat.
FI893340A (fi) Foerfarande foer att erhaolla farmaceutiska sammansaettningar foer att hindra smittbara koenssjukdomar.
DK489189A (da) Farmaceutisk praeparat
FI893643A (fi) Farmaceutiska kompositioner.
DE68907177D1 (de) Dosierungsform.
FI890488A0 (fi) Vaextextrakt innehaollande farmaceutiska preparat samt foerfarande foer framstaellning daerav.
NO890453L (no) Artropodicide preparater.
DE3576118D1 (de) Pharmazeutische praeparate.
DE3682960D1 (de) Pharmazeutische praeparate.
DK603988D0 (da) Farmaceutisk praeparat
NO874193D0 (no) Farmasoeytiske preparater.
FI905236A0 (fi) Deoxiribonukleosider innehaollande farmaceutiska konsistenser foer laekning av saor.
DK336489D0 (da) Farmaceutisk praeparat
DE68915203D1 (de) Pharmazeutische Mischungen.
DK16489A (da) Immunstimulerende praeparat.
IT8819791A0 (it) Peptidi ad attivita' farmaceutica.
FI875616A0 (fi) Farmaceutiska blandningar.
DE58905160D1 (de) Pharmazeutische zubereitung.
IT8819790A0 (it) Peptidi ad attivita' farmaceutica.

Legal Events

Date Code Title Description
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
SNR Assignments of patents or rights arising from examined patent applications

Owner name: BIOGAL GYOGYSZERGYAR RT.

Effective date: 20051115

TNT Modifications of names of proprietors of patents or applicants of examined patent applications

Owner name: TEVA GYOEGYSZERGYAR RESZVENYTARSASAG

Effective date: 20051115

TNT Modifications of names of proprietors of patents or applicants of examined patent applications

Owner name: TEVA GYOEGYSZERGYAR ZARTKOERUEN MUKOEDO RESZVENYTA

Effective date: 20061003

V4 Discontinued because of reaching the maximum lifetime of a patent

Effective date: 20090721